Medi-Cal Fee-For-Service (FFS) Pharmacy Benefit Section 1135 Waiver Flexibilities Relative to the 2019-Novel Coronavirus (COVID-19)

Print Friendly, PDF & Email

California Department of Health Care Services

Date: March 26, 2020

Medi-Cal Fee-For-Service (FFS) Pharmacy Benefit Section 1135 Waiver Flexibilities Relative to the 2019-Novel Coronavirus (COVID-19)

Based on the March 23, 2020 approval, DHCS is issuing the following guidance relative to temporary flexibilities in dispensing policies governing off-label and investigational use of medications under the Medi-Cal FFS pharmacy benefit, which will be in effect
until further notice.

Download PDF HERE